 |
SINGAPORE, May 15, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is proud to present to the market an exceptionally rare opportunity to acquire a freehold commercial building with individual strata titles per floor at 562 Serangoon Road, a highly visible and well-positioned property located in the heart of one of Singapore's most vibrant and culturally rich city fringe districts.
This four-storey commercial property occupies a land area of approximately 2,336 square feet and offers a total floor area of approximately 7,453 square feet, with individual strata titles for each level. The building presents a rare opportunity to acquire a freehold, non-conserved commercial asset with approved F&B use on the ground floor, making it highly attractive for a variety of investor profiles including owner-occupiers, landlords, corporates, hospitality operators, and family offices.
What truly distinguishes this property is its non-conserved status, an exceptional rarity along this stretch of Serangoon Road that is otherwise lined with conserved shophouses under architectural controls. As a Non-Conserved Envelope Control Site within a Secondary Settlement and zoned "Commercial" under the 2019 URA Master Plan with a plot ratio of 3.0, the site offers the buyer maximum flexibility to reconfigure, reposition, or redevelop the property to suit modern business needs. Subject to authorities' approvals, this opens the door to future-proofed uses such as serviced apartments, co-living residences, lifestyle clinics, co-working spaces, or creative concept showrooms, depending on owner and/or tenant demands and market trends.
Adding to its desirability is the building's ground-floor restaurant use approval, a tightly regulated designation in many central precincts. With F&B use already in place, owners can either operate their own flagship outlet or command premium rents from established tenants seeking main-road visibility in a city-fringe location.
The building's strata title per floor enhances its long-term investment appeal, offering flexibility for multi-use configurations or future strata divestment. This structure gives investors the freedom to either hold and lease the building as a whole or sell individual floors strategically over time. Few commercial properties in Singapore today combine such flexibility, rarity of tenure, and redevelopment potential in one asset. The guide price is set at a palatable S$23.5 million, in line with the latest valuation, offering exceptional value for a freehold standalone commercial building in a city-fringe locale with such versatile attributes.
Strategically located within a five-minute walk from both Farrer Park MRT Station and Boon Keng MRT Station (North-East Line), the property enjoys excellent connectivity and exposure, situated directly along Serangoon Road which is a major arterial road that channels strong pedestrian and vehicular traffic daily. The site is also well connected to key expressways including the CTE and PIE, and is within a short drive to popular areas such as Little India, Farrer Park, Bidadari, and the Kallang Riverside precinct.
Shopping malls such as City Square Mall and Mustafa Centre Mall are within a short walk, providing convenient access to daily essentials, dining, and entertainment. The area is also anchored by established medical and wellness hubs including Connexion at Farrer Park, an integrated healthcare and hospitality development comprising Farrer Park Hospital and One Farrer Hotel, as well as the Kwong Wai Shiu Hospital nearby. These major facilities not only draw a steady stream of visitors and medical tourists, but also support demand from wellness, aesthetic, and specialist clinics. Additionally, lifestyle enclaves such as Little India, Kampong Glam, and the emerging Boon Keng–Bendemeer precinct inject vibrancy into the district, while surrounding residential estates including HDB clusters in Whampoa and Boon Keng, and private developments like City Square Residences, Sturdee Residences, and 8 Riversuites, ensure a constant local population that drives daily footfall and commercial demand.
The broader Serangoon–Boon Keng–Lavender corridor is undergoing steady transformation, with new residential projects, community upgrades, and commercial developments on the horizon. This evolving landscape is expected to uplift overall land values and rental yields in the district, offering buyers strong future growth potential both in terms of capital appreciation and income.
"This is one of those real estate opportunities that checks all the right boxes," says Ms Sammi Lim, Founder and Executive Director of Brilliance Capital Pte. Ltd. "562 Serangoon Road offers freehold tenure, F&B approval, strata flexibility, and the freedom to enhance or reposition the building without conservation constraints. It is truly a rare gem. In today's tightly held urban market, finding a non-conserved commercial asset with such prominence and potential is incredibly rare."
She adds, "With its prime location near key districts, 562 Serangoon Road stands out as a highly desirable investment and owner-occupier asset. It offers excellent accessibility, high foot traffic, and strong future growth potential. For investors looking to unlock value over time, or businesses wanting their own city-fringe headquarters with branding visibility and upside, this is an asset not to be missed."
The property's pure commercial zoning ensures that the acquisition is not subject to Additional Buyer's Stamp Duty (ABSD) or Seller's Stamp Duty (SSD), a distinct advantage for both local and foreign buyers. This investment is suitable for a wide range of profiles, from private investors, corporates and family offices to developers and institutional funds looking for a unique foothold in central Singapore.
Brilliance Capital is the sole marketing agent for this Expression of Interest.
The Expression of Interest closes on 9 July 2025, Wednesday at 3:00 p.m.
Note to editors:
One high-resolution photograph of the properties are enclosed.
About Brilliance Capital Pte. Ltd.
Brilliance Capital is a premier real estate agency specializing in bespoke advisory and transaction services for high-net-worth individuals, family offices, property developers, and institutions in Singapore and globally.
Founded and led by Sammi Lim, a veteran in Singapore's property landscape , our team of top-tier professionals excels in selling and leasing luxury residential, commercial, and industrial properties, as well as collective sales. We also offer tailored consultancy and advisory services, addressing personal, professional, and investment needs with precision and care.
Backed by deep market insight and a robust international network, Brilliance Capital is dedicated to building lasting relationships and delivering exceptional real estate outcomes.
SINGAPORE, May 15, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is proud to present to the market an exceptionally rare opportunity to acquire a freehold commercial building with individual strata titles per floor at 562 Serangoon Road, a highly visible and well-positioned property located in the heart of one of Singapore's most vibrant and culturally rich city fringe districts.
This four-storey commercial property occupies a land area of approximately 2,336 square feet and offers a total floor area of approximately 7,453 square feet, with individual strata titles for each level. The building presents a rare opportunity to acquire a freehold, non-conserved commercial asset with approved F&B use on the ground floor, making it highly attractive for a variety of investor profiles including owner-occupiers, landlords, corporates, hospitality operators, and family offices.
What truly distinguishes this property is its non-conserved status, an exceptional rarity along this stretch of Serangoon Road that is otherwise lined with conserved shophouses under architectural controls. As a Non-Conserved Envelope Control Site within a Secondary Settlement and zoned "Commercial" under the 2019 URA Master Plan with a plot ratio of 3.0, the site offers the buyer maximum flexibility to reconfigure, reposition, or redevelop the property to suit modern business needs. Subject to authorities' approvals, this opens the door to future-proofed uses such as serviced apartments, co-living residences, lifestyle clinics, co-working spaces, or creative concept showrooms, depending on owner and/or tenant demands and market trends.
Adding to its desirability is the building's ground-floor restaurant use approval, a tightly regulated designation in many central precincts. With F&B use already in place, owners can either operate their own flagship outlet or command premium rents from established tenants seeking main-road visibility in a city-fringe location.
The building's strata title per floor enhances its long-term investment appeal, offering flexibility for multi-use configurations or future strata divestment. This structure gives investors the freedom to either hold and lease the building as a whole or sell individual floors strategically over time. Few commercial properties in Singapore today combine such flexibility, rarity of tenure, and redevelopment potential in one asset. The guide price is set at a palatable S$23.5 million, in line with the latest valuation, offering exceptional value for a freehold standalone commercial building in a city-fringe locale with such versatile attributes.
Strategically located within a five-minute walk from both Farrer Park MRT Station and Boon Keng MRT Station (North-East Line), the property enjoys excellent connectivity and exposure, situated directly along Serangoon Road which is a major arterial road that channels strong pedestrian and vehicular traffic daily. The site is also well connected to key expressways including the CTE and PIE, and is within a short drive to popular areas such as Little India, Farrer Park, Bidadari, and the Kallang Riverside precinct.
Shopping malls such as City Square Mall and Mustafa Centre Mall are within a short walk, providing convenient access to daily essentials, dining, and entertainment. The area is also anchored by established medical and wellness hubs including Connexion at Farrer Park, an integrated healthcare and hospitality development comprising Farrer Park Hospital and One Farrer Hotel, as well as the Kwong Wai Shiu Hospital nearby. These major facilities not only draw a steady stream of visitors and medical tourists, but also support demand from wellness, aesthetic, and specialist clinics. Additionally, lifestyle enclaves such as Little India, Kampong Glam, and the emerging Boon Keng–Bendemeer precinct inject vibrancy into the district, while surrounding residential estates including HDB clusters in Whampoa and Boon Keng, and private developments like City Square Residences, Sturdee Residences, and 8 Riversuites, ensure a constant local population that drives daily footfall and commercial demand.
The broader Serangoon–Boon Keng–Lavender corridor is undergoing steady transformation, with new residential projects, community upgrades, and commercial developments on the horizon. This evolving landscape is expected to uplift overall land values and rental yields in the district, offering buyers strong future growth potential both in terms of capital appreciation and income.
"This is one of those real estate opportunities that checks all the right boxes," says Ms Sammi Lim, Founder and Executive Director of Brilliance Capital Pte. Ltd. "562 Serangoon Road offers freehold tenure, F&B approval, strata flexibility, and the freedom to enhance or reposition the building without conservation constraints. It is truly a rare gem. In today's tightly held urban market, finding a non-conserved commercial asset with such prominence and potential is incredibly rare."
She adds, "With its prime location near key districts, 562 Serangoon Road stands out as a highly desirable investment and owner-occupier asset. It offers excellent accessibility, high foot traffic, and strong future growth potential. For investors looking to unlock value over time, or businesses wanting their own city-fringe headquarters with branding visibility and upside, this is an asset not to be missed."
The property's pure commercial zoning ensures that the acquisition is not subject to Additional Buyer's Stamp Duty (ABSD) or Seller's Stamp Duty (SSD), a distinct advantage for both local and foreign buyers. This investment is suitable for a wide range of profiles, from private investors, corporates and family offices to developers and institutional funds looking for a unique foothold in central Singapore.
Brilliance Capital is the sole marketing agent for this Expression of Interest.
The Expression of Interest closes on 9 July 2025, Wednesday at 3:00 p.m.
Note to editors:
One high-resolution photograph of the properties are enclosed.
About Brilliance Capital Pte. Ltd.
Brilliance Capital is a premier real estate agency specializing in bespoke advisory and transaction services for high-net-worth individuals, family offices, property developers, and institutions in Singapore and globally.
Founded and led by Sammi Lim, a veteran in Singapore's property landscape , our team of top-tier professionals excels in selling and leasing luxury residential, commercial, and industrial properties, as well as collective sales. We also offer tailored consultancy and advisory services, addressing personal, professional, and investment needs with precision and care.
Backed by deep market insight and a robust international network, Brilliance Capital is dedicated to building lasting relationships and delivering exceptional real estate outcomes.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
FOR SALE BY EXPRESSION OF INTEREST: Freehold Non-Conserved Commercial Building at 562 Serangoon Road
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
